Lifevantage Corp

LifeVantage Corp develops and sells nutrigenomic wellness products, combining dietary supplements, skin and hair care, pet supplements, and nootropic energy drinks with a direct-selling model. The company also offers independent consultants a commission-based sales opportunity, making consultant recruitment and retention central to its business.

4,9 %

77,6 %

2,8 %

−20,1 %

1.89

1.09

— Lifevantage Corp
%
Dietary supplements65% Nutrigenomic activators and wellness supplements sold under Protandim®, LifeVantage®, and PhysIQ brands.
Weight management and metabolic wellness15% Products aimed at appetite, metabolism, and wellness routines, including the MindBody GLP-1 System™.
Skin and hair care10% TrueScience® branded topical products and Liquid Collagen for beauty and personal care.
Nootropics and energy5% AXIO® energy drink mixes designed for focus, energy, and performance.
Pet wellness5% Petandim® supplement formulated to support oxidative stress management in dogs.

LifeVantage sells primarily to end consumers through independent consultants, so customer demand is shaped by both...

  • Independent consultantsprimary

    They buy products to resell and earn commissions, making the direct-selling network the core route to market.

  • Health and wellness consumersprimary

    They purchase nutrigenomic supplements and wellness systems for everyday health routines and repeat consumption.

  • Weight management userssecondary

    They buy the MindBody GLP-1 System™ and related products for appetite, metabolism, and wellness support.

  • Beauty and personal care consumerssecondary

    They purchase TrueScience® and Liquid Collagen products for skin and hair care benefits.

  • Pet ownersemerging

    They buy Petandim® for companion-animal wellness, a smaller but distinct niche segment.

LifeVantage reports two operating regions: the Americas and Asia/Pacific & Europe. Its disclosed country markets...

  • Two reporting regions: Americas and Asia/Pacific & Europe
  • United States is the key market for the MindBody GLP-1 launch
  • Japan is the largest disclosed market in Asia/Pacific & Europe
  • Operations span Australia, New Zealand, Greater China, and Europe
  • Philippines was closed in June 2025; Iceland launched in September 2025

LifeVantage is focused on launching new products, especially the MindBody GLP-1 System™, to expand consultant...

01
Scale MindBody GLP-1 System™short-term

The launch is a key growth driver and has already been cited as the main revenue contributor in the U.S. and Japan.

02
Strengthen consultant networkmedium-term

The direct-selling model depends on attracting and retaining consultants who generate customer demand.

03
Optimize market footprintmedium-term

Selective market entry and exit help focus resources on markets with better economics and execution.

The business is highly dependent on independent consultants, so consultant attrition or weaker recruiting can quickly...

high

Dependence on independent consultants

Revenue depends on consultants attracting and retaining customers, so network churn directly affects sales.

Scope
Direct-selling channel
Materiality
high
high

Product launch execution risk

Growth is tied to successful adoption of new products like MindBody GLP-1 System™.

Scope
New product rollout
Materiality
high
medium

Regulatory and claims risk

Nutraceutical and wellness products can face scrutiny over efficacy, labeling, and marketing claims.

Scope
Dietary supplements and direct marketing
Materiality
high
medium

Foreign exchange and regional demand volatility

A meaningful share of revenue comes from non-U.S. markets, making results sensitive to currency and local demand shifts.

Scope
Japan, Australia/New Zealand, Greater China, Europe
Materiality
medium
medium

Liquidity and financing risk

The company may need external funding if cash flow weakens and strategic needs rise.

Scope
Working capital and credit facility
Materiality
medium
Revenue recognition in direct selling
Affects quarterly revenue comparability and trend interpretation
Commissions and incentives
Can materially move operating margin quarter to quarter
Inventory valuation
May require write-downs that reduce gross margin
Stock-based compensation
Affects SG&A and reported profitability

: 28.4.2026